Rigel Pharmaceuticals Stock Market Value
| RIGL Stock | USD 27.88 1.18 4.42% |
| Symbol | Rigel |
Rigel Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rigel Pharmaceuticals. If investors know Rigel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rigel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.48) | Earnings Share 0.27 | Revenue Per Share 8.979 | Quarterly Revenue Growth 0.966 | Return On Assets 0.0461 |
The market value of Rigel Pharmaceuticals is measured differently than its book value, which is the value of Rigel that is recorded on the company's balance sheet. Investors also form their own opinion of Rigel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rigel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rigel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rigel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rigel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rigel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rigel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Rigel Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rigel Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rigel Pharmaceuticals.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in Rigel Pharmaceuticals on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Rigel Pharmaceuticals or generate 0.0% return on investment in Rigel Pharmaceuticals over 30 days. Rigel Pharmaceuticals is related to or competes with Fortress Biotech, Reviva Pharmaceuticals, Pieris Pharmaceuticals, Cidara Therapeutics, X4 Pharmaceuticals, Mereo BioPharma, and Inozyme Pharma. Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic d... More
Rigel Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rigel Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rigel Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.32 | |||
| Information Ratio | 0.1797 | |||
| Maximum Drawdown | 55.18 | |||
| Value At Risk | (4.39) | |||
| Potential Upside | 9.1 |
Rigel Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rigel Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rigel Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Rigel Pharmaceuticals historical prices to predict the future Rigel Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.161 | |||
| Jensen Alpha | 1.06 | |||
| Total Risk Alpha | 0.3103 | |||
| Sortino Ratio | 0.3612 | |||
| Treynor Ratio | 0.5993 |
Rigel Pharmaceuticals Backtested Returns
Rigel Pharmaceuticals is moderately volatile given 3 months investment horizon. Rigel Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.21, which implies the firm had a 0.21% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.4% are justified by taking the suggested risk. Use Rigel Pharmaceuticals Semi Deviation of 2.46, coefficient of variation of 503.74, and Risk Adjusted Performance of 0.161 to evaluate company specific risk that cannot be diversified away. Rigel Pharmaceuticals holds a performance score of 16 on a scale of zero to a hundred. The company holds a Beta of 2.2, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Rigel Pharmaceuticals will likely underperform. Use Rigel Pharmaceuticals downside variance, and the relationship between the sortino ratio and accumulation distribution , to analyze future returns on Rigel Pharmaceuticals.
Auto-correlation | 0.74 |
Good predictability
Rigel Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Rigel Pharmaceuticals time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rigel Pharmaceuticals price movement. The serial correlation of 0.74 indicates that around 74.0% of current Rigel Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.74 | |
| Spearman Rank Test | 0.61 | |
| Residual Average | 0.0 | |
| Price Variance | 2.79 |
Rigel Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Rigel Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Rigel Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Rigel Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Rigel Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Rigel Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Rigel Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Rigel Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Rigel Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Rigel Pharmaceuticals Lagged Returns
When evaluating Rigel Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Rigel Pharmaceuticals stock have on its future price. Rigel Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Rigel Pharmaceuticals autocorrelation shows the relationship between Rigel Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Rigel Pharmaceuticals.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Rigel Pharmaceuticals Correlation, Rigel Pharmaceuticals Volatility and Rigel Pharmaceuticals Alpha and Beta module to complement your research on Rigel Pharmaceuticals. For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Rigel Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.